In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?

dc.date.accessioned	2023-03-06T07:32:05Z
dc.date.available	2023-03-06T07:32:05Z
dc.date.issued	2021
dc.identifier.citation	Rheumatol Int. 2021 Nov;41(11):1915-1924. doi: 10.1007/s00296-021-04939-8. Epub 2021 Jul 5.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100156
dc.relation.isversionof	10.1007/s00296-021-04939-8
dc.relation.isversionof	10.1007/s00296-021-04939-8
dc.title	In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?
dc.relation.journal	Rheumatol Int
dc.identifier.doi	10.1007/s00296-021-04939-8
dc.contributor.author	Yagiz B
dc.contributor.author	Yagiz B
dc.contributor.author	Coskun BN
dc.contributor.author	Pehlivan Y
dc.contributor.author	Dalkilic E
dc.contributor.author	Kiraz S
dc.contributor.author	Yazisiz V
dc.contributor.author	Kucuksahin O